ArticleGenetics2026
Conservation and divergence within the Arabidopsis TPL/TPR corepressor family.
Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
Abstract
The TOPLESS (TPL) and TOPLESS-RELATED (TPR1-TPR4) corepressors, collectively the Arabidopsis TPL/TPR family, are recruited by client proteins to regulate nearly every major plant regulatory program. Here, we dissect the conservation and divergence between paralogs using a combination of higher-order genetics, transcriptomics, and a synthetic repression assay. TPL, TPR1, and TPR4 were found to act as the primary repressors for many pathways (including rosette leaf number, flowering time, immune responses, and auxin-regulated root architecture), while TPR2 and TPR3 played a lesser or sometimes opposite regulatory role. Natural variation among the 5 paralogs in the EAR-binding pocket subdivided the family into 3 subtypes: TPL/TPR1, TPR2/TPR3 and TPR4, and this variation at least partially explained observed differences between mutant phenotypes. In addition, cell-type-specific expression of EAR-containing effectors was used to tune root architecture, providing a possible route to engineering other TPL/TPR-regulated pathways. These results suggest a model where the TPL/TPR family balances robustness under stable conditions with the need for flexibility during cell fate transitions or stress responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.